跳至主要内容
临床试验/NCT00390260
NCT00390260已完成3 期

Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Rofecoxib 50 mg and Hydrocodone 7.5 mg With Acetaminophen 750 mg in Patients With Postoperative Arthroscopic Pain

Merck Sharp & Dohme LLC0 个研究点目标入组 420 人开始时间: 2002年2月最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
420
主要终点
Total Pain Relief over 6 hours following a single oral dose compared to placebo.

研究概览

简要总结

Study the effect of rofecoxib 50 mg compared to both placebo, and hydrocodone 7.5 mg with acetaminophen 750 mg, to treat moderate to severe pain following arthroscopic knee surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Elective outpatient arthroscopic knee surgery expected to last <= 90 minutes using general anesthesia
  • Patients must experience moderate to severe pain following surgery
  • Patient must be in general good health as judged by the primary investigator

排除标准

  • Osteoarthritis; rheumatoid arthritis
  • Allergy/sensitivity to aspirin, ibuprofen, indomethacin, other NSAIDs, COX-2 inhibitors (e.g., rofecoxib, celecoxib), hydrocodone, acetaminophen
  • Asthma associated with nasal polyps
  • Any arthroscopic knee surgery in the past 6 months

结局指标

主要结局

Total Pain Relief over 6 hours following a single oral dose compared to placebo.

时间窗: 6 hours

次要结局

  • Total Pain Relief over 6 hours following a single oral dose compared to hydrocodone + acetaminophen.(6 hours)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验